ATE120645T1 - Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen. - Google Patents

Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen.

Info

Publication number
ATE120645T1
ATE120645T1 AT87309685T AT87309685T ATE120645T1 AT E120645 T1 ATE120645 T1 AT E120645T1 AT 87309685 T AT87309685 T AT 87309685T AT 87309685 T AT87309685 T AT 87309685T AT E120645 T1 ATE120645 T1 AT E120645T1
Authority
AT
Austria
Prior art keywords
treatment
methods
coagulation disorders
therapeutic preparations
therapeutic
Prior art date
Application number
AT87309685T
Other languages
English (en)
Inventor
Donogh Paul O'brien
Gordon Allen Vehar
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25453974&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE120645(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE120645T1 publication Critical patent/ATE120645T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT87309685T 1986-11-04 1987-11-02 Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen. ATE120645T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92697786A 1986-11-04 1986-11-04

Publications (1)

Publication Number Publication Date
ATE120645T1 true ATE120645T1 (de) 1995-04-15

Family

ID=25453974

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87309685T ATE120645T1 (de) 1986-11-04 1987-11-02 Verfahren und therapeutische zubereitungen für die behandlung von gerinnungsstörungen.

Country Status (8)

Country Link
EP (1) EP0266993B1 (de)
JP (1) JP2758162B2 (de)
AT (1) ATE120645T1 (de)
CA (1) CA1317878C (de)
DE (1) DE3751218T2 (de)
ES (1) ES2073391T3 (de)
NZ (1) NZ222434A (de)
ZA (1) ZA878249B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589173A (en) 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
AU631603B2 (en) * 1989-02-02 1992-12-03 Teijin Limited Detection of human tissue factor activator
US6749853B1 (en) 1992-03-05 2004-06-15 Board Of Regents, The University Of Texas System Combined methods and compositions for coagulation and tumor treatment
PT988056E (pt) 1997-01-22 2003-09-30 Univ Texas Metodos e composicoes de factor tecidual para o tratamento da coagulacao e de tumores
WO2000002587A1 (en) 1998-07-13 2000-01-20 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
US6596847B2 (en) 1998-07-15 2003-07-22 Genentech, Inc. Tissue factor protein variants
US6703494B2 (en) 2000-03-16 2004-03-09 Genentech, Inc. Anti-tissue factor antibodies with enhanced anticoagulant potency
EP1749536A1 (de) * 2005-08-03 2007-02-07 Thrombotargets Europe, S.L. Aktivierte Stimulatoren des Faktors X als antihämorrhagisches Mittel für die topische Anwendung
US7772371B2 (en) 2005-08-03 2010-08-10 Thrombotargets Corporation Stimulators of Factor X activated (FXa) as new topical antihemorrhagic agents
US20180111977A1 (en) * 2015-03-23 2018-04-26 Dana Genetic A/S Recombinant soluble human tissue factor, method of its production and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL64879C (de) * 1944-05-20
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin

Also Published As

Publication number Publication date
JPS63218625A (ja) 1988-09-12
EP0266993A3 (en) 1988-07-27
DE3751218T2 (de) 1995-11-09
CA1317878C (en) 1993-05-18
EP0266993B1 (de) 1995-04-05
JP2758162B2 (ja) 1998-05-28
DE3751218D1 (de) 1995-05-11
EP0266993A2 (de) 1988-05-11
NZ222434A (en) 1990-06-26
ZA878249B (en) 1989-07-26
ES2073391T3 (es) 1995-08-16

Similar Documents

Publication Publication Date Title
ATE198712T1 (de) Verfahren und zusammensetzungen für die spezifische koagulation von tumorgefässen
DE68919361D1 (de) Therapeutische zusammensetzungen für die behandlung von myocard-infarkten.
DE3751470T2 (de) Pentigetide zur Behandlung von nicht-IgE-vermittelten entzündlichen Erkrankungen.
DE69200675D1 (de) Verwendung von Droloxifen bei der Behandlung von Knochenerkrankungen.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ATE235907T1 (de) Verwendung von kompetitiven progesteronantagonisten für die herstellung von arzneimitteln zur behandlung von dysfunktionellen uterinen blutungen
DE3751218T2 (de) Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.
DE68921413D1 (de) Verbindungen und Zusammensetzungen zur Anwendung bei Methoden zur Behandlung und Prophylaxe von Pneumocystis Carinii Pneumonia und anderen Krankheiten.
NO913129D0 (no) Nytt trombolytisk middel.
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE69007486T2 (de) Verwendung von calciumantagonisten für die behandlung von narben.
ATE25969T1 (de) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten.
DE68905076T2 (de) Pharmazeutische Zusammensetzung für die Behandlung von Hautwunden.
DE68908445T2 (de) Mittel zur Behandlung von Lebererkrankungen.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE68914886T2 (de) Mittel zur Behandlung von Raynaud's Krankheit.
ATE91886T1 (de) Praeparat zur behandlung von erektionsstoerungen.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE68905479D1 (de) Transdermate magensafthemmende wirkstoffe zur behandlung von magen-darm-erkrankungen.
ATE95061T1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
IT8919216A0 (it) Dispositivo per la cura chirurgica dell'astigmatismo.
ATE76571T1 (de) Zusammensetzung zur behandlung der haut.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time